FDA Approves JUVEDERM XC, The Latest Advancement In Hyaluronic Acid DermalFillers From Allergan, Inc., For A More Comfortable Injection Experience (NAPSA)—There’s encouraging news for anyone looking to instantly smooth the wrinkles around the nose and mouth but is concerned about pain. Now available nationwide, JUVEDERM XC the introduction of JUVEDERM XC, it often took up to 30 minutes for an anesthetic block to take effect. The new formulation provides the same smooth, longlasting results as demonstrated with existing formulations of JUVEDERM and now offers a more comfortable treatment experience and potentially less time spent in the physician’s office compared to the non-lido- from Allergan, Inc. contains li- docaine for enhanced comfort during treatmentof the “parentheses” lines between the nose and mouth. “The ‘no pain, no gain’ mental- ity has definitely played a role in the way women over the years have thought about aesthetic caine JUVEDERM formulation. “JUVEDERMis the first and only hyaluronic acid dermalfiller approved by the FDAto last up to one year from initial treatment?,” said Dr. Wechsler. “My patients are satisfied with treatment treatments. However, that is changing with recent advance- ments in aesthetic medicine,” said Amy Wechsler, M.D., board-certified dermatologist and psychiatrist. “In the clinical trial leading up to the U.S. Food and Drug Administration (FDA) approval of JUVEDERM XC, 93 percent of patients reported less pain when treated with JUVEDERM XC compared to the non-lidocaine JUVEDERM formulation’. Patients can now receive the same smooth results as demonstrated with JUVEDERM but enjoy a more com- fortable injection experience.” JUVEDERM XC with 0.3 per- cent lidocaine numbs the treatment area within seconds, potentially reducing the need for an additional anesthetic. Before results, and JUVEDERM has steadily gained popularity since its introduction.” For more information about JUVEDERM dermalfillers and to find a local physician, please visit www.Juvederm.com and become a fan of the official JUVEDERM Face- book page. ween ee eee eee eee ee eee WORE wn ee ee eee eee Important JUVEDERM Information JUVEDERM injectable gel (including JUVEDERM Ultra, JUVEDERM Ultra Plus, JUVEDERM Ultra XC, and JUVEDERM Ultra Plus XC) is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate lasting 7 days or less and included temporary injection site reactions like redness, pain, firmness, swelling and bumps. JUVEDERM is not for people with severe allergies. For more information, please click on the “About Safety” link at www.juvederm.com orcall the Allergan Product Support line at (877) 345-5372. JUVEDERM injectable gel is available by prescription only. 2010 Allergan, Inc. Irvine, CA 92612. JUVEDERM is a mark owned by Allergan Industries SAS APC70XR10 1. Weinkle SH, Bank DE, Boyd CM, Gold MH, Thomas JA, Murphy DK. A multicenter, doubleblind, randomized controlled study of the safety and effectiveness of JUVEDERM injectable gel with and without lidocaine. J Cosmet Dermatol. 2009 Sep;8(3):205-10. 2. Pinsky MA, Thomas JA, Murphy DK, Walker PS; for the JuvEDERM vs Zyplast Nasolabial Fold Study Group. JUVEDERM Injectable gel: A multicenter, doubleblind, randomized study of safety and effectiveness. Aesthetic Surg J. 2008; 28(1): 17-23.
